Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2020 Filed Apr 3, 2020 16:27 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 520 | $19.21 | $9,989.20 |
DisclosureSEC source: 0001562180-20-002880 · primarydocument.xml · nonDerivative · entry 1 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,082 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2020, pursuant to an election made in December 2019. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2020. F3 · balance_after: Includes 6,810 restricted stock units. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:53 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 943 | $19.21 | $18,115.03 |
DisclosureSEC source: 0001562180-20-002902 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,545 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2020, pursuant to an election made in December 2019. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2020. F3 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:27 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 611 | $19.21 | $11,737.31 |
DisclosureSEC source: 0001562180-20-002879 · primarydocument.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,311 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2020, pursuant to an election made in December 2019. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2020. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 23:52 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 93 | $17.44 | $1,622.37 |
DisclosureSEC source: 0001562180-20-002814 · primarydocument.xml · nonDerivative · entry 3 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,836 F2 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 198 RSUs. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.12 to $17.76. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 17,349 restricted stock units. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 23:52 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001562180-20-002814 · primarydocument.xml · derivative · entry 4 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,455 Underlying: Common Stock · 5,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option is fully vested. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 23:52 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 5,000 | $18.00 | $90,000.00 |
DisclosureSEC source: 0001562180-20-002814 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,929 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2019. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 23:52 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
Exercise / conversionCommon Stock | 5,000 | $2.96 | $14,800.00 |
DisclosureSEC source: 0001562180-20-002814 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2020 Filed Mar 20, 2020 21:03 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $11.46 | $19,103.82 |
DisclosureSEC source: 0001562180-20-002653 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,526 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 13,699 restricted stock units. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 16:12 UTC |
WALT DAVID RDirector
|
PurchaseCommon Stock | 54,064 | $16.66 | $900,911.68 |
DisclosureSEC source: 0001562180-20-002581 · primarydocument.xml · nonDerivative · entry 1 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,276,374 F1 · price: This transaction was executed in multiple trades at prices ranging from $16.0737 to $16.8709. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 566 | $16.04 | $9,080.56 |
DisclosureSEC source: 0001562180-20-002580 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,566 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 1,807 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.88 to $16.25. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 25,520 restricted stock units. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 566 | $16.04 | $9,080.56 |
DisclosureSEC source: 0001562180-20-002579 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,929 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 1,807 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.88 to $16.25. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 17,647 restricted stock units. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 16:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 5,500 | $20.53 | $112,915.00 |
DisclosureSEC source: 0001562180-20-002429 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,140,600 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.37 to $20.54. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 206,624 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · derivative · entry 9 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,507 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 600 | $22.81 | $13,687.02 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · nonDerivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 183,566 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $22.75 to $22.93. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,700 | $21.79 | $37,037.05 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 184,166 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $21.57 to $22.50. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $22.99 | $36,784.00 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,107 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $23.59 | $54,246.88 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 185,866 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.31 to $23.90. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $23.47 | $37,552.00 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 22:46 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-002273 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 310 | $22.97 | $7,121.38 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,100 F6 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 661 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $22.90 to $22.99. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · balance_after: Includes 206,624 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,020 | $22.93 | $69,234.71 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,410 F4 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 6,462 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $22.90 to $22.99. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,135 | $22.86 | $25,941.45 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149,430 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.83 to $23.20. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:50 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 4,365 | $22.40 | $97,782.55 |
DisclosureSEC source: 0001562180-20-002183 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,565 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.83 to $22.80. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:49 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 46 | $22.93 | $1,054.57 |
DisclosureSEC source: 0001562180-20-002172 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,495 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 148 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.90 to $22.99. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,454 restricted stock units. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:49 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 115 | $22.93 | $2,636.42 |
DisclosureSEC source: 0001562180-20-002171 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,132 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 368 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.90 to $22.99. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 27,327 restricted stock units. Read SEC document |
| February 21, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · derivative · entry 9 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,707 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| February 21, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $27.98 | $64,358.60 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · nonDerivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 188,166 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F7 · price: This transaction was executed in multiple trades at prices ranging from $27.67 to $28.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| February 21, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $28.26 | $45,216.00 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 21, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,307 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 100 | $28.58 | $2,858.36 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 190,466 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $28.57 to $28.59. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,200 | $28.11 | $61,846.84 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 190,566 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $27.57 to $28.43. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $28.29 | $45,266.08 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $27.89 to $28.65. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 00:14 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-001497 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:19 UTC |
Fry John JGeneral Counsel & Secretary
|
GrantStock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001438 · primarydocument.xml · derivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2030-02-18 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:19 UTC |
Fry John JGeneral Counsel & Secretary
|
GrantCommon Stock | 11,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001438 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,645 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 33,645 restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC |
Duffy David C.SVP R&D and CTO
|
GrantStock Option (right to buy) · Derivative | 15,167 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001434 · primarydocument.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,167 Underlying: Common Stock · 15,167 shares Expires 2030-02-18 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC |
Duffy David C.SVP R&D and CTO
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001434 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,193 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 14,771 restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:18 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 90,992 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001435 · primarydocument.xml · derivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,992 Underlying: Common Stock · 90,992 shares Expires 2030-02-18 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:18 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
GrantCommon Stock | 38,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001435 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,154,930 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 213,747 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:19 UTC |
Chaubal AmolChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 21,666 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001437 · primarydocument.xml · derivative · entry 2 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,666 Underlying: Common Stock · 21,666 shares Expires 2030-02-18 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:19 UTC |
Chaubal AmolChief Financial Officer
|
GrantCommon Stock | 9,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001437 · primarydocument.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,545 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 27,545 restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:19 UTC |
Mattoon DawnSr. VP, Research Products
|
GrantStock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001436 · primarydocument.xml · derivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2030-02-18 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:19 UTC |
Mattoon DawnSr. VP, Research Products
|
GrantCommon Stock | 11,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001436 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,247 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 27,665 restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
GrantStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001562180-20-001433 · primarydocument.xml · derivative · entry 5 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2030-02-18 F6 · derivative.exercise_date: The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001562180-20-001433 · primarydocument.xml · derivative · entry 4 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,455 Underlying: Common Stock · 5,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option is fully vested. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
GrantCommon Stock | 8,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001433 · primarydocument.xml · nonDerivative · entry 3 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,541 F4 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 18, 2021 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F1 · balance_after: Includes 19,602 restricted stock units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 5,000 | $27.84 | $139,194.00 |
DisclosureSEC source: 0001562180-20-001433 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,184 F2 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $27.4100 to $28.4099. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 19,602 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.